RSSCategory: Pharmaceuticals

Three in ten adults with type 2 diabetes resist insulin therapy

October 6, 2017
Three in ten adults with type 2 diabetes resist insulin therapy

Three in ten adults with type 2 diabetes resist the much-needed insulin therapy, a study has found. On average, these patients delay insulin for about two years, researchers report in Diabetic Medicine. “This matters to patients because insulin therapy is typically offered to patients with high blood sugar levels,” said senior study author Dr. Alexander [...]

Continue Reading

New drugs specifically designed to treat migraine currently in the pipeline

September 25, 2017
New drugs specifically designed to treat migraine currently in the pipeline

Migraine is listed by the World Health Organization (WHO) as the third most prevalent illness in the world, behind only tooth decay and tension-type headaches. It affects over 38 million Americans, including approximately 28 million women, who are afflicted at a rate three times that of men. But despite its prevalence, migraine — the condition [...]

Continue Reading

WHO calls on SEA nations to cooperate to make drugs, treatment accessible

September 11, 2017
WHO calls on SEA nations to cooperate to make drugs, treatment accessible

The World Health Organization (WHO) has called on Southeast Asian countries to work together to make medical treatment and drugs more affordable for the citizens. The countries were asked to take bold action ensuring citizens access to safe efficacious, quality and affordable medical products. The WHO also wants more emphasis to be given on leveraging [...]

Continue Reading

Novartis makes history with US approval of first “living drug” cancer therapy

September 4, 2017
Novartis makes history with US approval of first “living drug” cancer therapy

Swiss multinational pharmaceutical company Novartis made history as the US Food and Drug Administration (FDA) approved its tailor-made “living drug” therapy against cancer. Dubbed “CAR-T”, the treatment is the first to redesign a patient’s own immune system so it attacks cancer. The drug is tailor-made to each patient, unlike conventional therapies such as surgery or [...]

Continue Reading

Drug combination found to be highly effective against heart diseases

August 28, 2017
Drug combination found to be highly effective against heart diseases

Scientists in a major international study has found that the combination of two drugs – rivaroxaban and aspirin – is more effective in preventing further heart complications in people with cardiovascular diseases (CVDs) as compared to only aspirin or only rivaroxaban. Rivaroxaban, often known by the brand name Xarelto, is an anticoagulant, aspirin is an [...]

Continue Reading

Scientists use plants in new polio vaccine breakthrough

August 16, 2017
Scientists use plants in new polio vaccine breakthrough

The world may have taken a step towards a polio-free future as researchers make a breakthrough in vaccine development against the disease. An international consortium of scientists at the John Innes Centre in Norwich, UK was able to produce a new poliovirus vaccine by growing virus-like particles (VLPs), which are non-pathogenic mimics of the virus, [...]

Continue Reading

Hepatitis drugs are becoming more affordable

July 31, 2017
Hepatitis drugs are becoming more affordable

Drugs therapies to cure hepatitis C and treat hepatitis B are becoming more affordable as prices are dropping dramatically, giving hope to 325 million people living with the viral liver disease that can be fatal, the World Health Organization (WHO) said. A generic antiviral drug for hepatitis C, which can be cured in three months, [...]

Continue Reading

Corning partners with Merck, Pfizer for new injectable drug packaging project

July 21, 2017
Corning partners with Merck, Pfizer for new injectable drug packaging project

Corning Inc., an American manufacturer of specialty glass and ceramics, is making a US$500 million investment with US pharmaceutical giants Merck and Pfizer to manufacture a new kind of glass for injectable drug vials, US President Donald Trump announced. At a White House event, Trump said the effort will create nearly 1,000 jobs at facilities [...]

Continue Reading

Meningitis vaccine lowered gonorrhea risk by over 30% in New Zealand

July 19, 2017
Meningitis vaccine lowered gonorrhea risk by over 30% in New Zealand

A mass vaccination campaign in New Zealand against meningitis also proved to be effective in protecting people against gonorrhea, lowering the risk of the disease by more than 30%, researchers reported. Although the bacteria that cause gonorrhea and the bacteria that cause meningitis are related, the result of the vaccination campaign is still surprising news. [...]

Continue Reading

Novartis’ pioneering cancer gene therapy drug get US panel support

July 17, 2017
Novartis’ pioneering cancer gene therapy drug get US panel support

A pioneering cancer drug treatment developed by Swiss multinational pharmaceutical company Novartis AG has received support from an advisory panel to the US Food and Drug Administration (FDA), which could lead to the drug becoming the first gene therapy to be approved in the US. The panel voted 10-0 that the drug, tisagenlecleucel, should be [...]

Continue Reading